On June 28, the second wave of drugstore chain stores has been opened, and the public has filed for the listing. Going public also means that the next step will be a frenzy of mergers and acquisitions. The already listed single-minded, yifeng pharmacies and general dispensaries compete for market share through acquisitions. On the basis of the state-sponsored drug store chain development, chain pharmacies speed up the process of merger and acquisition, and a large number of independent pharmacies disappear in China.
Go public
As the number of independent pharmacies continues to decline, the chain stores have a new wave of listings. According to the knowledge, from the end of last year to may this year, the people who gargle the jade common people, the great ginseng Lin, jian jia all submitted the application for the listing. In December 2016, the public issued the prospectus for the initial public offering of shares (a-shares). According to the prospectus, gargle civilians are planning to land on the Shanghai stock exchange, issuing no more than 43.7 million shares and raising about 1 billion yuan. The fund is mainly used for marketing network construction project, modern logistics project and medical chain information service platform.
In April, the company released its prospectus, which, according to the prospectus, was to issue no less than 40 million shares, raising a total of 1.8 billion yuan. It is mainly used for the construction project of pharmaceutical chain marketing network, the construction project of yulin pharmaceutical logistics center, the information construction project and the supplementary working capital project. In may, the proper prospectus disclosure of health, landing Shanghai stock exchange, public offering of not more than 13.25 million shares, plans to raise capital of 509 million yuan, will be on building new chain stores, information system upgrades, channel marketing platform construction and so on all three big projects. Overseas markets such as Europe and the United States and analysis of the industry that giant has become a scale, compared to domestic chain pharmacies has just started, the market space, and on the integration of mergers and acquisitions, a chance to become a new hot spot of the current capital layout, it has great development opportunities for chain drug firms.
Accelerated merger
The relaunch of the listing also means that retail pharmacies will enter a high tide. Mergers and acquisitions are the main means of market share for chain drugstores, which can be seen from the single-minded, yifeng pharmacy and the people's pharmacy.
According to relevant statistics, there have been 43 mergers and acquisitions since the listing, and the main targets are local pharmacies. Yi feng first mentioned in the annual report, after the big pharmacy in public to use medicine retail industry mergers and acquisitions gold period, increase the pace of industry mergers and acquisitions, strive to finish is equivalent to 1000 stores in the next three years sales targets.
One not to be named, analysts said the next three years retail chain pharmaceutical industry structure will change, 500 billion yuan market can accommodate 15 listed companies, to accelerate the acquisition more stores is its main way of chain pharmacies in recent years. Xie zilong, chairman of the people's general pharmacy, has said that the existing retail pharmacy chain is low, and the development of the drug retail market will gradually shift from the number of stores to the chain concentration. In the next three or five years, it is still the golden age of drug store integration, merger and acquisition and reorganization.
According to xie, large-scale mergers and acquisitions are only a process, and integration and optimization is the purpose. It is easier to take advantage of the synergistic effect in the integration of the merger and acquisition. With the development of medical separation, the value of professional services will become more and more important, and professional services will become the key to the future transformation and success of the pharmaceutical retail industry and the basis of differentiating competition.
The number of independent pharmacies has plummeted
In the case of drug store chains and the rush of drugstore chains, single pharmacies or accelerated elimination. From 2013 to 2016, the number of drugstore chains increased and the number of independent pharmacies continued to decrease, according to the annual report on food and drug regulatory statistics released by the state administration of food and drug administration. In 2016, the number of chain stores exceeded the number of independent pharmacies for the first time. According to the data, as of the end of November 2016, there were 46.60 million licensed enterprises in the country, including 5,609 retail chains and 220,000 retail chain stores. There are 226,000 retail pharmacies. Monomer drugstores gradually disappear on the one hand, influenced by policy advocates the retail pharmacy industry concentration, on the other hand is the new revision of GSP certification, fly, two votes factors such as increase the cost of drugstore specification lead to monomer drugstores ultimately choose to shut down or be acquired.
At the end of 2016 the ministry of commerce issued the national medicine circulation industry development plan (2016-2020) ", in 2020 to foster the formation of a group of network covering the whole country, intensive and informatization degree higher large medicine circulation enterprises. The annual sales of pharmaceutical wholesale enterprises accounted for over 40% of the total pharmaceutical retail market; Drug retail chain rate of more than 50%. Drug retail industry competition is intense, rising store rents for retail pharmacies especially monomer drugstores face bigger cost pressures, pharmacy and pharmacy need equipped with licensed pharmacists to further increase monomer artificial cost. A drugstore employee to Beijing business newspaper reporters, pharmacy with licensed pharmacists cost is about 5000-6000 yuan a month, a pharmacy retail market competition is intense, monomer drugstores revenue situation is not optimistic, many pharmacies to afford the fees. In addition, the new GSP (" drug-handling quality management norms ") to store the information storage and automatic temperature measurement, cold chain management, equipment, validation more rigid requirements, such as monomer drugstores standard is difficult. |
